Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial
在SWOG S0016试验中,微小残留病灶状态可预测接受化疗免疫疗法治疗的滤泡性淋巴瘤患者的预后。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288057
Danilov, Alexey V; Li, Hongli; Shadman, Mazyar; Rimsza, Lisa; Zebari, Ahmad; Smith, Sonali M; LeBlanc, Michael; Friedberg, Jonathan W; Carlson, Christopher; Song, Joo Y